About This Event
Kailera (Nasdaq: KLRA), an advanced clinical-stage biotechnology company focused on elevating the next era of obesity care, visits the Nasdaq MarketSite in Times Square.
In honor of their Initial Public Offering, Ron Renaud, President and CEO, rings the Opening Bell.